-
Microbial-Based Oral Health Solutions for Companion Animals Partnership
A global innovator in microbial, natural, science-based ingredients seeks academic partnerships to develop novel oral health solutions for dogs and other companion animals. -
Supportive Ingredients for Healthier Weight Management
Global specialty ingredients company seeks innovative, science-backed ingredient solutions to support individuals on weight-management journeys by improving nutrition. -
Ongoing: Johnson & Johnson Innovation Collaboration Opportunities
Johnson & Johnson Innovation seeks academic partnerships across multiple therapeutic areas to advance breakthrough research from early-stage concepts to clinical applications. -
Data & AI Fueling R&D of Tomorrow QuickFire Challenge: Singapore & Beyond
Johnson & Johnson's challenge seeks novel AI/ML innovations that can transform drug discovery and development processes, with opportunities for global innovators who demonstrate interest in leveraging Singapore's innovation ecosystem -
Johnson & Johnson: Polyphonic™ AI Fund for Surgery QuickFire Challenge
Johnson & Johnson MedTech's challenge seeking AI innovations to improve surgical decision-making, strengthen data management processes, and drive surgical efficiency in connected operating rooms. -
2026 Ono Pharma Breakthrough Science Initiative Awards
Vanderbilt may nominate 2 candidates to submit an LOI to the Ono Pharma Foundation’s Breakthrough Science Initiative Awards Program. -
Sanofi iNext 2025-2026
A pitching competition designed to identify and incubate breakthrough "moon-shot" ideas that push the boundaries of traditional R&D. -
Novel Evaluation Systems and Biomarkers for Gene Therapy in Neurodegenerative Diseases and Immunology
Daiichi Sankyo is seeking innovative oligonucleotide-based strategies to precisely modulate RNA expression for therapeutic applications. -
Seeking In Vivo and In Vitro Models Exhibiting Resistance to Immune Checkpoint Inhibitors
Daiichi Sankyo invites academics, experts, technologies, centres of excellence, research projects, spinouts, and biotech assets for in vivo/in vitro models showing tumor-intrinsic resistance to ICIs (esp. PD-1/PD-L1 in solid tumors); clear MoR and lab/clinical relevance required. -
Seeking Approaches to Reduce the Application Cost of an Agrochemical Active Ingredient
Certis Belchim invites SMEs, startups, academics, centres of excellence, research projects, and spinouts (ideally with industrial experience) for scalable tech to cut metobromuron production to 6-8 €/kg or formulations halving its dose rate; lab-proofed concepts required.